Management of EGFR Mutant NSCLC Patients and Future Directions (excluding Resistance to EGFR TKIs)
0% Complete
Course Overview
NA
Course Content
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Objectives
NA
Target Audience
NA
Faculty & Disclosure
Faculty
Roy S. Herbst, MD, PhD, FACP, FASCO
Disclosure
Roy S. Herbst, MD, PhD, FACP, FASCO discloses no such relationships exist
Accreditation
NA
